Literature DB >> 19520886

Sulforaphane: from chemoprevention to pancreatic cancer treatment?

Johanna W Lampe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520886     DOI: 10.1136/gut.2008.166694

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.

Authors:  B Karthik Grandhi; Arvind Thakkar; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-26

2.  Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Nutr Cancer       Date:  2011-08-29       Impact factor: 2.900

3.  Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.

Authors:  Rakesh K Srivastava; Su-Ni Tang; Wenyu Zhu; Daniel Meeker; Sharmila Shankar
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

4.  Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study.

Authors:  Vladimir J Lozanovski; Georgios Polychronidis; Wolfgang Gross; Negin Gharabaghi; Arianeb Mehrabi; Thilo Hackert; Peter Schemmer; Ingrid Herr
Journal:  Invest New Drugs       Date:  2019-06-27       Impact factor: 3.850

5.  Sulforaphane promotes C. elegans longevity and healthspan via DAF-16/DAF-2 insulin/IGF-1 signaling.

Authors:  Zhimin Qi; Huihui Ji; Monika Le; Hanmei Li; Angela Wieland; Sonja Bauer; Li Liu; Michael Wink; Ingrid Herr
Journal:  Aging (Albany NY)       Date:  2021-01-20       Impact factor: 5.682

6.  HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells.

Authors:  Ming-Shun Wu; Gi-Shih Lien; Shing-Chuan Shen; Liang-Yo Yang; Yen-Chou Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-11       Impact factor: 2.629

7.  Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.

Authors:  Dhruvitkumar Sutaria; Balagangadhar Karthik Grandhi; Arvind Thakkar; Jeffrey Wang; Sunil Prabhu
Journal:  Int J Oncol       Date:  2012-09-21       Impact factor: 5.650

8.  The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.

Authors:  A Arlt; H Schäfer; H Kalthoff
Journal:  Oncogenesis       Date:  2012-11-26       Impact factor: 7.485

9.  A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells.

Authors:  Laura Mezzanotte; Na An; Isabel M Mol; Clemens W G M Löwik; Eric L Kaijzel
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.